These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33318043)

  • 21. Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments.
    Jones LA; Goodacre S
    Emerg Med J; 2009 Nov; 26(11):783-5. PubMed ID: 19850799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children.
    Oberklaid F; Mellis CM; Souëf PN; Geelhoed GC; Maccarrone AL
    Med J Aust; 1993 Jun; 158(11):751-3. PubMed ID: 8341188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous beta agonist in severe acute asthma.
    Cheong B; Reynolds SR; Rajan G; Ward MJ
    BMJ; 1988 Aug; 297(6646):448-50. PubMed ID: 3139138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of salbutamol with normal saline and salbutamol with magnesium sulphate in the treatment of severe acute asthma.
    Ahmed S; Sutradhar SR; Miah AH; Bari MA; Hasan MJ; Alam MK; Tariquzzaman M; Sarker CN
    Mymensingh Med J; 2013 Jan; 22(1):1-7. PubMed ID: 23416800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Children with asthma: will nebulised salbutamol reduce hospital admissions?
    Pearce JL; Wesley HM
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):595-7. PubMed ID: 3918686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of acute alteration in oxygen tension on the bronchodilator response to salbutamol in vitro and in vivo in man.
    Dagg KD; Clayton RA; Thomson LJ; Chalmers GW; McGrath JC; Thomson NC
    Pulm Pharmacol Ther; 2001; 14(2):99-105. PubMed ID: 11273790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.
    Delvaux M; Henket M; Lau L; Kange P; Bartsch P; Djukanovic R; Louis R
    Thorax; 2004 Feb; 59(2):111-5. PubMed ID: 14760148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a place for nebulised magnesium sulphate in the management of asthma?
    Lyons J
    Emerg Nurse; 2016 Nov; 24(7):28-33. PubMed ID: 27830597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated doses of salbutamol and aeroallergen sensitisation both increased salbutamol-induced hypoxia in children and adolescents with acute asthma.
    Ozer M; Buyuktiryaki B; Sahiner UM; Teksam O; Karaatmaca B; Soyer O; Sekerel BE
    Acta Paediatr; 2018 Apr; 107(4):647-652. PubMed ID: 29284188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial.
    Powell C; Kolamunnage-Dona R; Lowe J; Boland A; Petrou S; Doull I; Hood K; Williamson P;
    Lancet Respir Med; 2013 Jun; 1(4):301-8. PubMed ID: 24429155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous salbutamol: too much of a good thing?
    Tobin A
    Crit Care Resusc; 2005 Jun; 7(2):119-27. PubMed ID: 16548805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
    Bjermer L; Abbott-Banner K; Newman K
    Pulm Pharmacol Ther; 2019 Oct; 58():101814. PubMed ID: 31202957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway.
    Turner DL; Ford WR; Kidd EJ; Broadley KJ; Powell C
    Eur J Pharmacol; 2017 Apr; 801():79-85. PubMed ID: 28284753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute hyperoxia on the bronchodilator response to salbutamol in stable asthmatic patients.
    Dagg KD; Thomson LJ; Ramsay SG; Thomson NC
    Thorax; 1996 Aug; 51(8):853-4. PubMed ID: 8795678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD.
    Poole PJ; Saini R; Brodie SM; Black PN
    Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
    Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
    Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma.
    Javor E; Grle SP
    Pulm Pharmacol Ther; 2019 Apr; 55():31-37. PubMed ID: 30660759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
    Zainudin BM; Tolfree SE; Short M; Spiro SG
    Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled magnesium sulfate in the treatment of acute asthma.
    Blitz M; Blitz S; Beasely R; Diner BM; Hughes R; Knopp JA; Rowe BH
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003898. PubMed ID: 16235345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.